Document Details
Form
Filing Date
Oct 11, 2019
Document Date
Oct 09, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
EyePoint Pharmaceuticals
Issuer
EYEPOINT PHARMACEUTICALS, INC.
Filer
Mazzo David J
